Cardiol Therapeutics (CRDL) Cash from Restructuring (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Cash from Restructuring came in at $3448.4 in Q1 2026, down 17.14% YoY from $4162.0 in Q1 2025, and down 13.54% on a QoQ basis from $3988.5 in Q3 2025.
Cardiol Therapeutics (CRDL) Cash from Restructuring (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Cash from Restructuring data on file, last reported at $3448.4 in Q1 2026.
- Quarterly Cash from Restructuring fell 17.14% year-over-year to $3448.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15740.1 (down 14.37% YoY) and the FY2021 annual result came in at $10316.8, down 15.14% from the prior year.
- Cash from Restructuring slipped to $3448.4 in Q1 2026, from $3988.5 in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $4927.6 in Q1 2024 to a low of $1024.4 in Q2 2023.
- A 5-year average of $3254.5 and a median of $3988.5 in 2025 frame the typical range for Cash from Restructuring.
- Annual changes were most pronounced in 2023 — Cash from Restructuring slumped 46.32% — and 2024, when it jumped 354.37%.
- Tracing CRDL's Cash from Restructuring over 5 years: stood at $1695.3 in 2022, then soared by 161.23% to $4428.6 in 2023, then gained by 4.71% to $4637.3 in 2024, then fell by 13.99% to $3988.5 in 2025, then declined by 13.54% to $3448.4 in 2026.
- The last three Cash from Restructuring figures came in at $3448.4 (Q1 2026), $3988.5 (Q3 2025), and $4141.2 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,448.41 |
| Sep 30, 2025 | 3,988.50 |
| Jun 30, 2025 | 4,141.19 |
| Mar 31, 2025 | 4,161.99 |
| Sep 30, 2024 | 4,637.30 |
| Jun 30, 2024 | 4,654.44 |
| Mar 31, 2024 | 4,927.63 |
| Sep 30, 2023 | 4,428.59 |
| Jun 30, 2023 | 1,024.37 |
| Mar 31, 2023 | 1,209.40 |
| Sep 30, 2022 | 1,695.28 |
| Jun 30, 2022 | 1,908.30 |
| Mar 31, 2022 | 2,082.64 |
| Dec 31, 2021 | 2,322.09 |
| Sep 30, 2021 | 2,503.98 |
| Jun 30, 2021 | 2,714.74 |
| Mar 31, 2021 | 2,775.62 |
| Dec 31, 2020 | 2,915.57 |